{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:32:06Z","timestamp":1793039526795,"version":"4.5.0"},"reference-count":243,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Atherosclerosis serves as the primary catalyst for numerous cardiovascular diseases. Growing evidence suggests that the immune response is involved in every stage of atherosclerotic plaque evolution. Rapid, but not specific, innate immune arms, including neutrophils, monocytes\/macrophages, dendritic cells (DCs) and other innate immune cells, as well as pattern-recognition receptors and various inflammatory mediators, contribute to atherogenesis. The specific adaptive immune response, governed by T cells and B cells, antibodies, and immunomodulatory cytokines potently regulates disease activity and progression. In the inflammatory microenvironment, the heterogeneity of leukocyte subpopulations plays a very important regulatory role in plaque evolution. With advances in experimental techniques, the fine mechanisms of immune system involvement in atherosclerotic plaque evolution are becoming known. In this review, we examine the critical immune responses involved in atherosclerotic plaque evolution, in particular, looking at atherosclerosis from the perspective of evolutionary immunobiology. A comprehensive understanding of the interplay between plaque evolution and plaque immunity provides clues for strategically combating atherosclerosis.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1437821","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:34:06Z","timestamp":1727397246000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":33,"title":["Immunological perspectives on atherosclerotic plaque formation and progression"],"prefix":"10.3389","volume":"15","author":[{"given":"Hui","family":"Pi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xilong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2015.06.006","article-title":"Global overview of the epidemiology of atherosclerotic cardiovascular disease","volume":"46","author":"Barquera","year":"2015","journal-title":"Arch Med Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.redox.2017.01.007","article-title":"Angiogenesis in the atherosclerotic plaque","volume":"12","author":"Camar\u00e9","year":"2017","journal-title":"Redox Biol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","article-title":"Atherosclerosis","volume":"5","author":"Libby","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis","volume":"592","author":"Libby","year":"2021","journal-title":"Nature"},{"key":"B5","article-title":"Atherosclerosis: process, indicators, risk factors and new hopes","volume":"5","author":"Rafieian-Kopaei","year":"2014","journal-title":"Int J Prev Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.3390\/ijms23063346","article-title":"Pathophysiology of atherosclerosis","volume":"23","author":"Jebari-Benslaiman","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-198712000-00008","article-title":"Atherosclerosis and its evolution in childhood","volume":"294","author":"Berenson","year":"1987","journal-title":"Am J Med Sci"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs067","article-title":"Non-invasive anatomic and functional imaging of vascular inflammation and unstable plaque","volume":"33","author":"Camici","year":"2012","journal-title":"Eur Heart J"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1190312284","DOI":"10.1177\/03946320221092188","article-title":"Immune system and atherosclerosis: Hostile or friendly relationship","volume":"36","author":"Razeghian-Jahromi","year":"2022","journal-title":"Int J Immunopathology Pharmacol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/febs.14466","article-title":"A guide to chemokines and their receptors","volume":"285","author":"Hughes","year":"2018","journal-title":"FEBS J"},{"key":"B11","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3390\/cells10020226","article-title":"Inflammatory chemokines in atherosclerosis","volume":"10","author":"Gencer","year":"2021","journal-title":"Cells"},{"key":"B12","first-page":"367","article-title":"On the origin of species by means of natural selection, or the preservation of favoured races in the struggle for life","volume":"25","year":"1860","journal-title":"Br Foreign Medico-Chirurgical Rev"},{"key":"B13","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1126\/science.aan6828","article-title":"Single-cell transcriptomics to explore the immune system in health and disease","volume":"358","author":"Stubbington","year":"2017","journal-title":"Science"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.07.078","article-title":"The dynamic nature of coronary artery lesion morphology assessed by serial virtual histology intravascular ultrasound tissue characterization","volume":"55","author":"Kubo","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.10.069","article-title":"Intravascular ultrasound virtual histology derived thin cap fibroatheroma now you see it, now you don't","volume":"55","author":"Deliargyris","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"5293","DOI":"10.3390\/ijms20215293","article-title":"Immunobiology of atherosclerosis: A complex net of interactions","volume":"20","author":"Herrero-Fernandez","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00226","article-title":"The scavenger receptor SREC-i cooperates with toll-like receptors to trigger inflammatory innate immune responses","volume":"7","author":"Murshid","year":"2016","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00584-1","article-title":"How the immune system shapes atherosclerosis: roles of innate and adaptive immunity","volume":"22","author":"Roy","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/35025203","article-title":"Atherosclerosis","volume":"407","author":"Lusis","year":"2000","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-007-0212-8","article-title":"The endothelial glycocalyx: composition, functions, and visualization","volume":"454","author":"Reitsma","year":"2007","journal-title":"Pflugers Archiv: Eur J Physiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1475-2840-5-4","article-title":"Endothelial dysfunction: a comprehensive appraisal","volume":"5","author":"Esper","year":"2006","journal-title":"Cardiovasc Diabetol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.615503","article-title":"Perivascular adipose tissue as an indication, contributor to, and therapeutic target for atherosclerosis","volume":"11","author":"Liu","year":"2020","journal-title":"Front Physiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12933-018-0777-x","article-title":"Perivascular adipose tissue (PVAT) in atherosclerosis: a double-edged sword","volume":"17","author":"Qi","year":"2018","journal-title":"Cardiovasc Diabetology"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/bph.13705","article-title":"Perivascular adipose tissue inflammation in vascular disease","volume":"174","author":"Nosalski","year":"2017","journal-title":"Br J Pharmacol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/cvr\/cvx226","article-title":"And cardiovascular risk factors-a review","volume":"114","author":"Mundi","year":"2018","journal-title":"Cardiovasc Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0000000000000330","article-title":"The central role of arterial retention of cholesterol-rich apolipoprotein-b-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity","volume":"27","author":"Bor\u00e9n","year":"2016","journal-title":"Curr Opin Lipidology"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.2174\/1381612054865064","article-title":"Macrophage differentiation to foam cells","volume":"11","author":"Shashkin","year":"2005","journal-title":"Curr Pharm Design"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-017-1575-8","article-title":"Mechanisms of foam cell formation in atherosclerosis","volume":"95","author":"Chistiakov","year":"2017","journal-title":"J Mol Med (Berl)"},{"key":"B29","article-title":"Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis","volume":"140","author":"Clinton","year":"1992","journal-title":"Am J Pathol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1161\/circ.105.10.1158","article-title":"Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation","volume":"105","author":"Edfeldt","year":"2002","journal-title":"Circulation"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1161\/hc5001.100631","article-title":"Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL","volume":"104","author":"Xu","year":"2001","journal-title":"Circulation"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0403249101","article-title":"Lack of toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E","volume":"101","author":"Michelsen","year":"2004","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-019-0326-7","article-title":"Neutrophils as regulators of cardiovascular inflammation","volume":"17","author":"Silvestre-Roig","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.111.257535","article-title":"Multiple roles for neutrophils in atherosclerosis","volume":"110","author":"Soehnlein","year":"2012","journal-title":"Circ Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa8064","article-title":"Inflammation neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis","volume":"349","author":"Warnatsch","year":"2015","journal-title":"Sci (New York N.Y.)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.309692","article-title":"Neutrophil extracellular traps in atherosclerosis and atherothrombosis","volume":"120","author":"D\u00f6ring","year":"2017","journal-title":"Circ Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.07.017","article-title":"Innate lymphoid cells: 10 years on","volume":"174","author":"Vivier","year":"2018","journal-title":"Cell"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3489","article-title":"Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis","volume":"17","author":"Klose","year":"2016","journal-title":"Nat Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1354617","article-title":"Enrichment of type 1 innate lymphoid cells in the course of human atherosclerotic plaque development suggests contribution to atherogenesis","volume":"15","author":"Pertiwi","year":"2024","journal-title":"Front Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.113.302571","article-title":"Helix-loop-helix factor inhibitor of differentiation 3 regulates interleukin-5 expression and B-1a B cell proliferation","volume":"33","author":"Perry","year":"2013","journal-title":"Arteriosclerosis Thrombosis Vasc Biol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2017.04.030","article-title":"Innate lymphoid cells in atherosclerosis","volume":"816","author":"Engelbertsen","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/ni1582","article-title":"Functions of natural killer cells","volume":"9","author":"Vivier","year":"2008","journal-title":"Nat Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2005.01.046","article-title":"Identification of natural killer cells in human atherosclerotic plaque","volume":"180","author":"Bobryshev","year":"2005","journal-title":"Atherosclerosis"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000124923.95545.2c","article-title":"Depletion of natural killer cell function decreases atherosclerosis in low-density lipoprotein receptor null mice","volume":"24","author":"Whitman","year":"2004","journal-title":"Arteriosclerosis Thrombosis Vasc Biol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000024082.46387.38","article-title":"Inflammation in atherosclerosis: lesion formation in LDL receptor-deficient mice with perforin and lyst(beige) mutations","volume":"22","author":"Schiller","year":"2002","journal-title":"Arteriosclerosis Thrombosis Vasc Biol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvu016","article-title":"Natural killer (NK) cells augment atherosclerosis by cytotoxic-dependent mechanisms","volume":"102","author":"Selathurai","year":"2014","journal-title":"Cardiovasc Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.114.303566","article-title":"Dendritic cells in atherosclerosis: evidence in mice and humans","volume":"35","author":"Zernecke","year":"2015","journal-title":"Arteriosclerosis Thrombosis Vasc Biol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2011.07.001","article-title":"How dendritic cells shape atherosclerosis","volume":"32","author":"Koltsova","year":"2011","journal-title":"Trends Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"S1537","DOI":"10.1016\/j.vph.2018.04.006","article-title":"Innate and adaptive immunity in atherosclerosis","volume":"22","author":"Miteva","year":"2018","journal-title":"Vasc Pharmacol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.2MR0915-441R","article-title":"Biased signaling pathways via CXCR3 control the development and function of CD4+ T cell subsets","volume":"99","author":"Karin","year":"2016","journal-title":"J Leukocyte Biol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.107.147827","article-title":"CXCR3 antagonist NBI-74330 attenuates atherosclerotic plaque formation in LDL receptor-deficient mice","volume":"28","author":"van Wanrooij","year":"2008","journal-title":"Arteriosclerosis Thrombosis Vasc Biol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.678474","article-title":"CXCR6 promotes atherosclerosis by supporting t-cell homing, interferon-gamma production, and macrophage accumulation in the aortic wall","volume":"116","author":"Galkina","year":"2007","journal-title":"Circulation"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.308648","article-title":"CCR5+T-bet+FoxP3+ effector CD4 T cells drive atherosclerosis","volume":"118","author":"Li","year":"2016","journal-title":"Circ Res"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.520718","article-title":"Differential influence of chemokine receptors CCR2 and CXCR3 in development of atherosclerosis in vivo","volume":"112","author":"Veillard","year":"2005","journal-title":"Circulation"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.956730","article-title":"Chemokine receptor 7 knockout attenuates atherosclerotic plaque development","volume":"122","author":"Luchtefeld","year":"2010","journal-title":"Circulation"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000156889.22364.f1","article-title":"Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis","volume":"96","author":"Zhou","year":"2005","journal-title":"Circ Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.24.2919","article-title":"Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice","volume":"102","author":"Zhou","year":"2000","journal-title":"Circulation"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2019.05.009","article-title":"Disruption of the CCL1-CCR8 axis inhibits vascular treg recruitment and function and promotes atherosclerosis in mice","volume":"132","author":"Vila-Caballer","year":"2019","journal-title":"J Mol Cell Cardiol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1172\/JCI44925","article-title":"CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice","volume":"121","author":"Weber","year":"2011","journal-title":"J Clin Invest"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e152511","DOI":"10.1172\/jci.insight.152511","article-title":"IL-35 promotes CD4+Foxp3+ tregs and inhibits atherosclerosis via maintaining CCR5-amplified treg-suppressive mechanisms","volume":"6","author":"Shao","year":"2021","journal-title":"JCI Insight"},{"key":"B61","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1172\/JCI63108","article-title":"Adaptive immunity in atherogenesis: new insights and therapeutic approaches","volume":"123","author":"Lichtman","year":"2013","journal-title":"J Clin Invest"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033932","article-title":"TAP1-deficiency does not alter atherosclerosis development in apoe-\/- mice","volume":"7","author":"Kolbus","year":"2012","journal-title":"PloS One"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.001347","article-title":"Cytotoxic and proinflammatory CD8+ T lymphocytes promote development of vulnerable atherosclerotic plaques in apoE-deficient mice","volume":"127","author":"Kyaw","year":"2013","journal-title":"Circulation"},{"key":"B64","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1161\/ATVBAHA.114.303569","article-title":"Targeting B cells in atherosclerosis: closing the gap from bench to bedside","volume":"35","author":"Tsiantoulas","year":"2015","journal-title":"Arteriosclerosis Thrombosis Vasc Biol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH774>3.0.CO;2-N","article-title":"Adventitial infiltrates associated with advanced atherosclerotic plaques: structural organization suggests generation of local humoral immune responses","volume":"193","author":"Houtkamp","year":"2001","journal-title":"J Pathology"},{"key":"B66","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0021-9150(85)90164-9","article-title":"Immunoglobulins and complement components in human aortic atherosclerotic intima","volume":"55","author":"Vlaicu","year":"1985","journal-title":"Atherosclerosis"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2009.03.001","article-title":"The therapeutic potential of targeting B cells and anti-oxLDL antibodies in atherosclerosis","volume":"9","author":"van Leeuwen","year":"2009","journal-title":"Autoimmun Rev"},{"key":"B68","doi-asserted-by":"crossref","DOI":"10.1172\/JCI118853","article-title":"Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. demonstration of epitopes of oxidized low density lipoprotein in human plasma","volume":"98","author":"Palinski","year":"1996","journal-title":"J Clin Invest"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1172\/JCI7272","article-title":"Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice","volume":"109","author":"Caligiuri","year":"2002","journal-title":"J Clin Invest"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000039169.47943.EE","article-title":"B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice","volume":"22","author":"Major","year":"2002","journal-title":"Arteriosclerosis Thrombosis Vasc Biol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119892","article-title":"Immunoglobulin treatment reduces atherosclerosis in apo e knockout mice","volume":"102","author":"Nicoletti","year":"1998","journal-title":"J Clin Invest"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200420479","article-title":"IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis","volume":"114","author":"Binder","year":"2004","journal-title":"J Clin Invest"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20100155","article-title":"B cell depletion reduces the development of atherosclerosis in mice","volume":"207","author":"Ait-Oufella","year":"2010","journal-title":"J Exp Med"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1000033","article-title":"Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis","volume":"185","author":"Kyaw","year":"2010","journal-title":"J Immunol (Baltimore Md. 1950)"},{"key":"B75","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1600-065X.2007.00554.x","article-title":"Innate immunity, macrophage activation, and atherosclerosis","volume":"219","author":"Yan","year":"2007","journal-title":"Immunol Rev"},{"key":"B76","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3390\/biom8030080","article-title":"Research progress on the relationship between atherosclerosis and inflammation","volume":"8","author":"Zhu","year":"2018","journal-title":"Biomolecules"},{"key":"B77","volume-title":"The role of lipids and lipoproteins in atherosclerosis","author":"Linton","year":""},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114271","article-title":"Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man","volume":"84","author":"Yla-Herttuala","year":"1989","journal-title":"J Clin Invest"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-60327-029-8_24","article-title":"Oxidized low-density lipoprotein","volume":"610","author":"Parthasarathy","year":"2010","journal-title":"Methods Mol Biol (Clifton N.J.)"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2010.05.005","article-title":"Activation of TLR2 and TLR4 by minimally modified low-density lipoprotein in human macrophages and monocytes triggers the inflammatory response","volume":"71","author":"Ch\u00e1vez-S\u00e1nchez","year":"2010","journal-title":"Hum Immunol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.5551\/jat.19281","article-title":"Pathogenic role of modified LDL antibodies and immune complexes in atherosclerosis","volume":"20","author":"Lopes-Virella","year":"2013","journal-title":"J Atheroscl Thrombosis"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601563","article-title":"Oxidized low-density lipoprotein immune complex priming of the Nlrp3 inflammasome involves TLR and Fc\u03b3R cooperation and is dependent on CARD9","volume":"198","author":"Rhoads","year":"2017","journal-title":"J Immunol (Baltimore Md. 1950)"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.115.307312","article-title":"p38\u03b4 MAPK: A novel regulator of NLRP3 inflammasome activation with increased expression in coronary atherogenesis","volume":"36","author":"Rajam\u00e4ki","year":"2016","journal-title":"Arteriosclerosis Thrombosis Vasc Biol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.117.309575","article-title":"NLRP3 inflammasome inhibition by MCC950 reduces atherosclerotic lesion development in apolipoprotein E-deficient mice-brief report","volume":"37","author":"van der Heijden","year":"2017","journal-title":"Arteriosclerosis Thrombosis Vasc Biol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"e99","DOI":"10.1038\/emm.2014.38","article-title":"CD36, a scavenger receptor implicated in atherosclerosis","volume":"46","author":"Park","year":"2014","journal-title":"Exp Mol Med"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.99.24.3110","article-title":"Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions","volume":"99","author":"Kataoka","year":"1999","journal-title":"Circulation"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht532","article-title":"Endothelial overexpression of LOX-1 increases plaque formation and promotes atherosclerosis in vivo","volume":"35","author":"Akhmedov","year":"2014","journal-title":"Eur Heart J"},{"key":"B88","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.atherosclerosis.2006.11.031","article-title":"Lectin-like oxidized LDL receptor-1 (LOX-1) expression is associated with atherosclerotic plaque instability\u2013analysis in hypercholesterolemic rabbits","volume":"195","author":"Ishino","year":"2007","journal-title":"Atherosclerosis"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.107.149724","article-title":"Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet","volume":"100","author":"Mehta","year":"2007","journal-title":"Circ Res"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.118.313816","article-title":"Atherosclerosis","volume":"123","author":"Kobiyama","year":"2018","journal-title":"Circ Res"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12367","article-title":"Regulation of atherosclerotic plaque inflammation","volume":"278","author":"Back","year":"2015","journal-title":"J Intern Med"},{"key":"B92","doi-asserted-by":"publisher","first-page":"114471","DOI":"10.1016\/j.bcp.2021.114471","article-title":"Cell adhesion molecule-mediated therapeutic strategies in atherosclerosis: From a biological basis and molecular mechanism to drug delivery nanosystems","volume":"186","author":"Yin","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2011.10.012","article-title":"P-selectin glycoprotein ligand-1 deficiency leads to cytokine resistance and protection against atherosclerosis in apolipoprotein E deficient mice","volume":"220","author":"Luo","year":"2012","journal-title":"Atherosclerosis"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.771048","article-title":"P-selectin glycoprotein ligand-1 is highly expressed on ly-6Chi monocytes and a major determinant for ly-6Chi monocyte recruitment to sites of atherosclerosis in mice","volume":"117","author":"An","year":"2008","journal-title":"Circulation"},{"key":"B95","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/1440-1681.12539","article-title":"Integrated regulation of the cellular metabolism and function of immune cells in adipose tissue","volume":"43","author":"Oishi","year":"2016","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2016.11.014","article-title":"Sargachromenol protects against vascular inflammation by preventing TNF-alpha-induced monocyte adhesion to primary endothelial cells via inhibition of NF-kappaB activation","volume":"42","author":"Gwon","year":"2017","journal-title":"Int Immunopharmacol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.acc.2015.03.004","article-title":"Nuclear factor-kappaB activation as a pathological mechanism of lipid metabolism and atherosclerosis","volume":"70","author":"Yu","year":"2015","journal-title":"Adv Clin Chem"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.16.9052","article-title":"The NF-kappa B signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation","volume":"97","author":"Hajra","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1038\/nri3151","article-title":"Accessory molecules for toll-like receptors and their function","volume":"12","author":"Lee","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1038\/nrg2303","article-title":"Toll-like receptors\u2013taking an evolutionary approach","volume":"9","author":"Leulier","year":"2008","journal-title":"Nat Rev Genet"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.793869","article-title":"Increased inflammatory gene expression in ABC transporter-deficient macrophages: free cholesterol accumulation, increased signaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions","volume":"118","author":"Yvan-Charvet","year":"2008","journal-title":"Circulation"},{"key":"B102","doi-asserted-by":"publisher","first-page":"2060161234","DOI":"10.1177\/10742484241248046","article-title":"The role of JAK\/STAT signaling pathway and its downstream influencing factors in the treatment of atherosclerosis","volume":"29","author":"Zhang","year":"2024","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M704267200","article-title":"Role of the Jak\/STAT pathway in the regulation of interleukin-8 transcription by oxidized phospholipids in vitro and in atherosclerosis in vivo","volume":"282","author":"Gharavi","year":"2007","journal-title":"J Biol Chem"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0b013e32834aa701","article-title":"The wnt pathways in vascular disease: lessons from vascular development","volume":"22","author":"Tsaousi","year":"2011","journal-title":"Curr Opin Lipidol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvx253","article-title":"Endothelial-mesenchymal transition in atherosclerosis","volume":"114","author":"Souilhol","year":"2018","journal-title":"Cardiovasc Res"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.118.311367","article-title":"Brown adipocyte-specific PPARgamma (Peroxisome proliferator-activated receptor gamma) deletion impairs perivascular adipose tissue development and enhances atherosclerosis in mice","volume":"38","author":"Xiong","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"104803","DOI":"10.1016\/j.micpath.2021.104803","article-title":"The association of chlamydia pneumoniae infection with atherosclerosis: Review and update of in vitro and animal studies","volume":"154","author":"Khoshbayan","year":"2021","journal-title":"Microb Pathog"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.766560","article-title":"The effects of porphyromonas gingivalis on atherosclerosis-related cells","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"8074","DOI":"10.3390\/ijms22158074","article-title":"The role of gut microbiota on cholesterol metabolism in atherosclerosis","volume":"22","author":"Vourakis","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B110","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1161\/CIRCRESAHA.118.313234","article-title":"A proinflammatory gut microbiota increases systemic inflammation and accelerates atherosclerosis","volume":"124","author":"Brandsma","year":"2019","journal-title":"Circ Res"},{"key":"B111","doi-asserted-by":"publisher","first-page":"3832","DOI":"10.3390\/jcm11133832","article-title":"The role of CMV infection in primary lesions, development and clinical expression of atherosclerosis","volume":"11","author":"Cristescu","year":"2022","journal-title":"J Clin Med"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(00)00608-0","article-title":"Cytomegalovirus infection increases development of atherosclerosis in apolipoprotein-e knockout mice","volume":"156","author":"Hsich","year":"2001","journal-title":"Atherosclerosis"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvab260","article-title":"Heterogeneity of immune cells in human atherosclerosis revealed by scRNA-seq","volume":"117","author":"Vallejo","year":"2021","journal-title":"Cardiovasc Res"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12314","article-title":"The role of different monocyte subsets in the pathogenesis of atherosclerosis and acute coronary syndromes","volume":"82","author":"Idzkowska","year":"2015","journal-title":"Scandinavian J Immunol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S1074-7613(03)00174-2","article-title":"Blood monocytes consist of two principal subsets with distinct migratory properties","volume":"19","author":"Geissmann","year":"2003","journal-title":"Immunity"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1692665","article-title":"Heterogeneity of macrophages in atherosclerosis","volume":"119","author":"Stremmel","year":"2019","journal-title":"Thromb Haemostasis"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.5482\/HAMO-14-08-0030","article-title":"Monocyte subsets in atherosclerosis","volume":"35","author":"Hristov","year":"2015","journal-title":"Hamostaseologie"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2050-7771-2-1","article-title":"Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases","volume":"2","author":"Yang","year":"2014","journal-title":"biomark Res"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.21.6.1004","article-title":"Enzymatically degraded LDL preferentially binds to CD14(high) CD16(+) monocytes and induces foam cell formation mediated only in part by the class B scavenger-receptor CD36","volume":"21","author":"Kapinsky","year":"2001","journal-title":"Z]. Arterioscler Thromb Vasc Biol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2010.08.012","article-title":"Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors","volume":"33","author":"Cros","year":"2010","journal-title":"Immunity"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.13462","article-title":"The role of monocytosis and neutrophilia in atherosclerosis","volume":"22","author":"Chistiakov","year":"2018","journal-title":"J Cell Mol Med"},{"key":"B123","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1172\/JCI29950","article-title":"Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata","volume":"117","author":"Swirski","year":"2007","journal-title":"J Clin Invest"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1172\/JCI28549","article-title":"Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques","volume":"117","author":"Tacke","year":"2007","journal-title":"J Clin Invest"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.117.310739","article-title":"Endothelial protective monocyte patrolling in large arteries intensified by western diet and atherosclerosis","volume":"120","author":"Quintar","year":"2017","journal-title":"Circ Res"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2012.09.013","article-title":"Distribution of macrophage polarization markers in human atherosclerosis","volume":"225","author":"St\u00f6ger","year":"2012","journal-title":"Atherosclerosis"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1160\/TH11-05-0320","article-title":"Differentiation factors and cytokines in the atherosclerotic plaque micro-environment as a trigger for macrophage polarisation","volume":"106","author":"Wolfs","year":"2011","journal-title":"Thromb Haemostasis"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.115.306048","article-title":"Expansion of CD25+ innate lymphoid cells reduces atherosclerosis","volume":"35","author":"Engelbertsen","year":"2015","journal-title":"Arteriosclerosis Thrombosis Vasc Biol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"15781","DOI":"10.1038\/ncomms15781","article-title":"Type-2 innate lymphoid cells control the development of atherosclerosis in mice","volume":"8","author":"Newland","year":"2017","journal-title":"Nat Commun"},{"key":"B130","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12865-019-0330-z","article-title":"ILC2 transfers to apolipoprotein E deficient mice reduce the lipid content of atherosclerotic lesions","volume":"20","author":"Mantani","year":"2019","journal-title":"BMC Immunol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"5018975","DOI":"10.1155\/2020\/5018975","article-title":"ILC2 proliferated by IL-33 stimulation alleviates acute colitis in Rag1(-\/-) mouse through promoting M2 macrophage polarization","volume":"2020","author":"You","year":"2020","journal-title":"J Immunol Res"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1326440","article-title":"ILC2-mediated immune crosstalk in chronic (vascular) inflammation","volume":"14","author":"Kral","year":"2023","journal-title":"Front Immunol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1002\/emmm.201201374","article-title":"Interleukin-13 protects from atherosclerosis and modulates plaque composition by skewing the macrophage phenotype","volume":"4","author":"Cardilo-Reis","year":"2012","journal-title":"EMBO Mol Med"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.2741\/2692","article-title":"Macrophage activation and polarization","volume":"13","author":"Martinez","year":"2008","journal-title":"Front Bioscience A J Virtual Library"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2011.01.001","article-title":"Macrophages in skin injury and repair","volume":"216","author":"Mahdavian Delavary","year":"2011","journal-title":"Immunobiology"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2004.09.015","article-title":"The chemokine system in diverse forms of macrophage activation and polarization","volume":"25","author":"Mantovani","year":"2004","journal-title":"Trends Immunol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1200662","article-title":"Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction","volume":"189","author":"Zizzo","year":"2012","journal-title":"J Immunol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-013-9621-3","article-title":"The adenosine-dependent angiogenic switch of macrophages to an M2-like phenotype is independent of interleukin-4 receptor alpha (IL-4R\u03b1) signaling","volume":"36","author":"Ferrante","year":"2013","journal-title":"Inflammation"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1160\/TH03-02-0069","article-title":"Platelet factor 4 localization in carotid atherosclerotic plaques: correlation with clinical parameters","volume":"90","author":"Pitsilos","year":"2003","journal-title":"Thromb Haemostasis"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1160\/th07-09-0567","article-title":"CXCL4 in atherosclerosis: possible roles in monocyte arrest and macrophage foam cell formation","volume":"98","author":"Gleissner","year":"2007","journal-title":"Thromb Haemost"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2014.173","article-title":"Macrophage subsets in atherosclerosis","volume":"12","author":"Chinetti-Gbaguidi","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1161\/CIRCRESAHA.111.247577","article-title":"Activating transcription factor 1 directs mhem atheroprotective macrophages through coordinated iron handling and foam cell protection","volume":"110","author":"Boyle","year":"2012","journal-title":"Circ Res"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.10.852","article-title":"Hemoglobin directs macrophage differentiation and prevents foam cell formation in human atherosclerotic plaques","volume":"59","author":"Finn","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2009.2792","article-title":"Hemoglobin and heme scavenger receptors","volume":"12","author":"Nielsen","year":"2010","journal-title":"Antioxidants Redox Signaling"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-14-0621","article-title":"Macrophage phenotypes and their modulation in atherosclerosis","volume":"78","author":"De Paoli","year":"2014","journal-title":"Circ J Off J Japanese Circ Society"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.109.215715","article-title":"Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2","volume":"107","author":"Kadl","year":"2010","journal-title":"Circ Res"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.120.316903","article-title":"Meta-analysis of leukocyte diversity in atherosclerotic mouse aortas","volume":"127","author":"Zernecke","year":"2020","journal-title":"Circ Res"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abf7777","article-title":"Three tissue resident macrophage subsets coexist across organs with conserved origins and life cycles","volume":"7","author":"Dick","year":"2022","journal-title":"Sci Immunol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-020362","article-title":"Pf4-cre transgenic mice allow the generation of lineage-restricted gene knockouts for studying megakaryocyte and platelet function in vivo","volume":"109","author":"Tiedt","year":"2007","journal-title":"Blood"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.117.312509","article-title":"Single-cell RNA-seq reveals the transcriptional landscape and heterogeneity of aortic macrophages in murine atherosclerosis","volume":"122","author":"Cochain","year":"2018","journal-title":"Circ Res"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2017.03.031","article-title":"Galectin-3 binding protein, coronary artery disease and cardiovascular mortality: Insights from the LURIC study","volume":"260","author":"Gleissner","year":"2017","journal-title":"Atherosclerosis"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.107.159160","article-title":"Galectin-3 is an amplifier of inflammation in atherosclerotic plaque progression through macrophage activation and monocyte chemoattraction","volume":"28","author":"Papaspyridonos","year":"2008","journal-title":"Arteriosclerosis Thrombosis Vasc Biol"},{"key":"B153","article-title":"The function of cathepsins b, d, and x in atherosclerosis","volume":"6","author":"Zhao","year":"2016","journal-title":"Am J Cardiovasc Disease"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.124574","article-title":"Single-cell analysis of fate-mapped macrophages reveals heterogeneity, including stem-like properties, during atherosclerosis progression and regression","volume":"4","author":"Lin","year":"2019","journal-title":"JCI Insight"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.118.312804","article-title":"Transcriptome analysis reveals nonfoamy rather than foamy plaque macrophages are proinflammatory in atherosclerotic murine models","volume":"123","author":"Kim","year":"2018","journal-title":"Circ Res"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.06.054","article-title":"Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses","volume":"151","author":"Spann","year":"2012","journal-title":"Cell"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvac161","article-title":"Integrated single-cell analysis-based classification of vascular mononuclear phagocytes in mouse and human atherosclerosis","volume":"119","author":"Zernecke","year":"2023","journal-title":"Cardiovasc Res"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-101819-025146","article-title":"Dendritic cell regulation of T helper cells","volume":"39","author":"Yin","year":"2021","journal-title":"Annu Rev Immunol"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.2174\/1381612820666141013162528","article-title":"Dendritic cells: a double-edge sword in atherosclerotic inflammation","volume":"21","author":"Chistiakov","year":"2015","journal-title":"Curr Pharm Design"},{"key":"B160","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1146\/annurev.immunol.26.021607.090254","article-title":"Migration of dendritic cell subsets and their precursors","volume":"26","author":"Randolph","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1097\/00019501-200605000-00007","article-title":"Decreased number of circulating plasmacytoid dendritic cells in patients with atherosclerotic coronary artery disease","volume":"17","author":"Van Vr\u00e9","year":"2006","journal-title":"Coronary Artery Dis"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2007.03.067","article-title":"Peripheral-blood dendritic cells in men with coronary heart disease","volume":"100","author":"Shi","year":"2007","journal-title":"Am J Cardiol"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.642801","article-title":"Pathogen-sensing plasmacytoid dendritic cells stimulate cytotoxic t-cell function in the atherosclerotic plaque through interferon-alpha","volume":"114","author":"Niessner","year":"2006","journal-title":"Circulation"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.697789","article-title":"Synergistic proinflammatory effects of the antiviral cytokine interferon-alpha and toll-like receptor 4 ligands in the atherosclerotic plaque","volume":"116","author":"Niessner","year":"2007","journal-title":"Circulation"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2014.12.010","article-title":"Myeloid dendritic cells: Development, functions, and role in atherosclerotic inflammation","volume":"220","author":"Chistiakov","year":"2015","journal-title":"Immunobiology"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2011.09.014","article-title":"Flt3 signaling-dependent dendritic cells protect against atherosclerosis","volume":"35","author":"Choi","year":"2011","journal-title":"Immunity"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1172\/JCI64617","article-title":"Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs","volume":"123","author":"Subramanian","year":"2013","journal-title":"J Clin Invest"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.111.256529","article-title":"Plasmacytoid dendritic cells protect against atherosclerosis by tuning t-cell proliferation and activity","volume":"109","author":"Daissormont","year":"2011","journal-title":"Circ Res"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.046755","article-title":"Auto-antigenic protein-DNA complexes stimulate plasmacytoid dendritic cells to promote atherosclerosis","volume":"125","author":"D\u00f6ring","year":"2012","journal-title":"Circulation"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.112.251314","article-title":"Plasmacytoid dendritic cells play a key role in promoting atherosclerosis in apolipoprotein E-deficient mice","volume":"32","author":"Macritchie","year":"2012","journal-title":"Arteriosclerosis Thrombosis Vasc Biol"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.011090","article-title":"MHC class II-restricted antigen presentation by plasmacytoid dendritic cells drives proatherogenic T cell immunity","volume":"130","author":"Sage","year":"2014","journal-title":"Circulation"},{"key":"B172","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nri1996","article-title":"Steady-state and inflammatory dendritic-cell development","volume":"7","author":"Shortman","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/941396","article-title":"Dendritic cells in human atherosclerosis: from circulation to atherosclerotic plaques","volume":"2011","author":"Van Vr\u00e9","year":"2011","journal-title":"Mediators Inflammation"},{"key":"B174","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1161\/01.ATV.0000142812.03840.6f","article-title":"Chemokines: key regulators of mononuclear cell recruitment in atherosclerotic vascular disease","volume":"24","author":"Weber","year":"2004","journal-title":"Arteriosclerosis Thrombosis Vasc Biol"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.107.158675","article-title":"CX3CR1 deficiency impairs dendritic cell accumulation in arterial intima and reduces atherosclerotic burden","volume":"28","author":"Liu","year":"2008","journal-title":"Arteriosclerosis Thrombosis Vasc Biol"},{"key":"B176","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-020-0352-5","article-title":"T cell subsets and functions in atherosclerosis","volume":"17","author":"Saigusa","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2021.02.001","article-title":"Role of inflammatory cytokines in genesis and treatment of atherosclerosis","volume":"32","author":"Biros","year":"2022","journal-title":"Trends Cardiovasc Med"},{"key":"B178","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cca.2014.12.007","article-title":"Interferon-\u03b3 in foam cell formation and progression of atherosclerosis","volume":"441","author":"Yu","year":"2015","journal-title":"Clinica Chimica Acta; Int J Clin Chem"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000059419.11002.6E","article-title":"Influence of interferon-gamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse","volume":"23","author":"Buono","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119465","article-title":"IFN-gamma potentiates atherosclerosis in ApoE knock-out mice","volume":"99","author":"Gupta","year":"1997","journal-title":"J Clin Invest"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64820-1","article-title":"Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E-\/- mice","volume":"157","author":"Whitman","year":"2000","journal-title":"Am J Pathol"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0409015102","article-title":"T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses","volume":"102","author":"Buono","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.12.040194.003223","article-title":"Acquisition of lymphokine-producing phenotype by CD4+ T cells","volume":"12","author":"Seder","year":"1994","journal-title":"Annu Rev Immunol"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1161\/hq0302.104905","article-title":"Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor-\/- mice","volume":"22","author":"King","year":"2002","journal-title":"Arteriosclerosis Thrombosis Vasc Biol"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2007.060857","article-title":"Interleukin-4 does not influence development of hypercholesterolemia or angiotensin II-induced atherosclerotic lesions in mice","volume":"171","author":"King","year":"2007","journal-title":"Am J Pathology"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.06.016","article-title":"MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion","volume":"41","author":"Oliphant","year":"2014","journal-title":"Immunity"},{"key":"B187","doi-asserted-by":"publisher","first-page":"112073","DOI":"10.1016\/j.celrep.2023.112073","article-title":"Crosstalk between ILC2s and Th2 cells varies among mouse models","volume":"42","author":"Gurram","year":"2023","journal-title":"Cell Rep"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.114.303567","article-title":"IL-17 and Th17 cells in atherosclerosis: subtle and contextual roles","volume":"35","author":"Taleb","year":"2015","journal-title":"Arteriosclerosis Thrombosis Vasc Biol"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1783","article-title":"Thymic self-reactivity selects natural interleukin 17-producing T cells that can regulate peripheral inflammation","volume":"10","author":"Marks","year":"2009","journal-title":"Nat Immunol"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.05.001","article-title":"Plasticity of CD4+ T cell lineage differentiation","volume":"30","author":"Zhou","year":"2009","journal-title":"Immunity"},{"key":"B191","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nature06880","article-title":"Control of t(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor","volume":"453","author":"Quintana","year":"2008","journal-title":"Nature"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1663","article-title":"Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells","volume":"9","author":"Zhang","year":"2008","journal-title":"Nat Immunol"},{"key":"B193","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","article-title":"The IL-17 family of cytokines in health and disease","volume":"50","author":"Mcgeachy","year":"2019","journal-title":"Immunity"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901126","article-title":"Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice","volume":"183","author":"Erbel","year":"2009","journal-title":"J Immunol (Baltimore Md. 1950)"},{"key":"B195","doi-asserted-by":"publisher","first-page":"196ra100","DOI":"10.1126\/scitranslmed.3006133","article-title":"Transforming growth factor-\u03b2 signaling in T cells promotes stabilization of atherosclerotic plaques through an interleukin-17-dependent pathway","volume":"5","author":"Gister\u00e5","year":"2013","journal-title":"Sci Trans Med"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0900408106","article-title":"Identification of IL-17-producing FOXP3+ regulatory T cells in humans","volume":"106","author":"Voo","year":"2009","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B197","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.clim.2008.12.008","article-title":"IL-1beta and IL-2 convert human treg into T(H)17 cells","volume":"131","author":"Deknuydt","year":"2009","journal-title":"Clin Immunol (Orlando Fla.)"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2011.139","article-title":"Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin","volume":"131","author":"Bovenschen","year":"2011","journal-title":"J Invest Dermatol"},{"key":"B199","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3390\/metabo10070279","article-title":"Regulatory T cell metabolism in atherosclerosis","volume":"10","author":"Baardman","year":"2020","journal-title":"Metabolites"},{"key":"B200","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1161\/01.ATV.0000259365.31469.89","article-title":"Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis","volume":"27","author":"Mor","year":"2007","journal-title":"Arteriosclerosis Thrombosis Vasc Biol"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1038\/nm1343","article-title":"Natural regulatory T cells control the development of atherosclerosis in mice","volume":"12","author":"Ait-Oufella","year":"2006","journal-title":"Nat Med"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1172\/JCI18607","article-title":"Disruption of TGF-beta signaling in T cells accelerates atherosclerosis","volume":"112","author":"Robertson","year":"2003","journal-title":"J Clin Invest"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.85.8.e17","article-title":"Protective role of interleukin-10 in atherosclerosis","volume":"85","author":"Mallat","year":"1999","journal-title":"Circ Res"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.117.312513","article-title":"Atlas of the immune cell repertoire in mouse atherosclerosis defined by single-cell RNA-sequencing and mass cytometry","volume":"122","author":"Winkels","year":"2018","journal-title":"Circ Res"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.119.312399","article-title":"Adventitial cell atlas of wt (Wild type) and apoE (Apolipoprotein E)-deficient mice defined by single-cell RNA sequencing","volume":"39","author":"Gu","year":"2019","journal-title":"Arteriosclerosis Thrombosis Vasc Biol"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.120.312137","article-title":"Heterogeneity of T cells in atherosclerosis defined by single-cell RNA-sequencing and cytometry by time of flight","volume":"41","author":"Winkels","year":"2021","journal-title":"Arteriosclerosis Thrombosis Vasc Biol"},{"key":"B207","doi-asserted-by":"publisher","first-page":"156049","DOI":"10.1016\/j.cyto.2022.156049","article-title":"IL-7: Comprehensive review","volume":"160","author":"Winer","year":"2022","journal-title":"Cytokine"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.006381","article-title":"Innate response activator B cells aggravate atherosclerosis by stimulating T helper-1 adaptive immunity","volume":"129","author":"Hilgendorf","year":"2014","journal-title":"Circulation"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.111.248542","article-title":"B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions","volume":"109","author":"Kyaw","year":"2011","journal-title":"Circ Res"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.112.249235","article-title":"Refining the role of B cells in atherosclerosis","volume":"32","author":"Perry","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.4.2245","article-title":"TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology","volume":"173","author":"Sasaki","year":"2004","journal-title":"J Immunol (Baltimore Md. 1950)"},{"key":"B212","doi-asserted-by":"publisher","first-page":"e60430","DOI":"10.1371\/journal.pone.0060430","article-title":"BAFF receptor mAb treatment ameliorates development and progression of atherosclerosis in hyperlipidemic ApoE(-\/-) mice","volume":"8","author":"Kyaw","year":"2013","journal-title":"PloS One"},{"key":"B213","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/CIRCRESAHA.111.256438","article-title":"B-cell aortic homing and atheroprotection depend on Id3","volume":"110","author":"Doran","year":"2012","journal-title":"Circ Res"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.117.310678","article-title":"Follicular B cells promote atherosclerosis via T cell-mediated differentiation into plasma cells and secreting pathogenic Immunoglobulin G","volume":"38","author":"Tay","year":"2018","journal-title":"Arteriosclerosis Thrombosis Vasc Biol"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.119.313064","article-title":"Russell ross memorial lecture in vascular biology: B lymphocyte-mediated protective immunity in atherosclerosis","volume":"40","author":"Upadhye","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.589654","article-title":"Targeting IL-1\u03b2 in the treatment of atherosclerosis","volume":"11","author":"Mai","year":"2020","journal-title":"Front Immunol"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.09.028","article-title":"Interleukin-1 beta as a target for atherosclerosis therapy: Biological basis of CANTOS and beyond","volume":"70","author":"Libby","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32814-3","article-title":"Relationship of c-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial","volume":"391","author":"Ridker","year":"2018","journal-title":"Lancet (London England)"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.110.214585","article-title":"Carotid intima-media thickness in psoriatic arthritis: differences between tumor necrosis factor-\u03b1 blockers and traditional disease-modifying antirheumatic drugs","volume":"31","author":"Di Minno","year":"2011","journal-title":"Arteriosclerosis Thrombosis Vasc Biol"},{"key":"B220","doi-asserted-by":"publisher","first-page":"e14110","DOI":"10.1111\/dth.14110","article-title":"Long-term impact of adalimumab therapy on biomarkers of systemic inflammation in psoriasis: Results of a 2 year study","volume":"33","author":"Gkalpakiotis","year":"2020","journal-title":"Dermatologic Ther"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00520-1","article-title":"IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"397","author":"Ridker","year":"2021","journal-title":"Lancet (London England)"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2010.11.005","article-title":"Effect of CC chemokine receptor 2 CCR2 blockade on serum c-reactive protein in individuals at atherosclerotic risk and with a single nucleotide polymorphism of the monocyte chemoattractant protein-1 promoter region","volume":"107","author":"Gilbert","year":"2011","journal-title":"Am J Cardiol"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0590-4","article-title":"Single-cell immune landscape of human atherosclerotic plaques","volume":"25","author":"Fernandez","year":"2019","journal-title":"Nat Med"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2021.04.010","article-title":"PD-1\/PD-L1 immune checkpoints: Tumor vs atherosclerotic progression","volume":"519","author":"Liang","year":"2021","journal-title":"Clinica Chimica Acta; Int J Clin Chem"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-024-00945-0","article-title":"Targeting pro-inflammatory T cells as a novel therapeutic approach to potentially resolve atherosclerosis in humans","volume":"34","author":"Fan","year":"2024","journal-title":"Cell Res"},{"key":"B226","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3390\/ijms24010128","article-title":"Malondialdehyde as an important key factor of molecular mechanisms of vascular wall damage under heart diseases development","volume":"24","author":"Lankin","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000067937.93716.DB","article-title":"Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences","volume":"23","author":"Fredrikson","year":"2003","journal-title":"Arteriosclerosis Thrombosis Vasc Biol"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R400007-JLR200","article-title":"A review of CETP and its relation to atherosclerosis","volume":"45","author":"de Grooth","year":"2004","journal-title":"J Lipid Res"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2015.06.004","article-title":"Reality of a vaccine in the prevention and treatment of atherosclerosis","volume":"46","author":"Garc\u00eda-Gonz\u00e1lez","year":"2015","journal-title":"Arch Med Res"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.13.7464","article-title":"Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype","volume":"97","author":"Lutgens","year":"2000","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx260","article-title":"The AT04A vaccine against proprotein convertase subtilisin\/kexin type 9 reduces total cholesterol, vascular inflammation, and atherosclerosis in APOE*3Leiden.CETP mice","volume":"38","author":"Landlinger","year":"2017","journal-title":"Eur Heart J"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-020-07041-6","article-title":"PCSK9Q\u03b2-003 vaccine attenuates atherosclerosis in apolipoprotein E-deficient mice","volume":"35","author":"Wu","year":"2021","journal-title":"Cardiovasc Drugs Ther"},{"key":"B233","doi-asserted-by":"publisher","first-page":"e37718","DOI":"10.1097\/MD.0000000000037718","article-title":"Co-stimulators CD40-CD40L, a potential immune-therapy target for atherosclerosis: A review","volume":"103","author":"Tian","year":"2024","journal-title":"Medicine"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000129505.34151.23","article-title":"Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents","volume":"109","author":"Sch\u00f6nbeck","year":"2004","journal-title":"Circulation"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.1038\/89058","article-title":"Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site","volume":"7","author":"Weitz-Schmidt","year":"2001","journal-title":"Nat Med"},{"key":"B236","article-title":"Matrix metalloproteases as a pharmacological target in cardiovascular diseases","volume":"19","author":"Hopps","year":"2015","journal-title":"Eur Rev For Med Pharmacol Sci"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-07-861237","article-title":"Neutrophil \u03b1-defensins promote thrombosis in vivo by altering fibrin formation, structure, and stability","volume":"133","author":"Abu-Fanne","year":"2019","journal-title":"Blood"},{"key":"B238","doi-asserted-by":"publisher","first-page":"e018993","DOI":"10.1161\/JAHA.120.018993","article-title":"Colchicine inhibits neutrophil extracellular trap formation in patients with acute coronary syndrome after percutaneous coronary intervention","volume":"10","author":"Vaidya","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.1016\/j.acvd.2020.04.007","article-title":"Colchicine and myocardial infarction: A review","volume":"113","author":"Akodad","year":"2020","journal-title":"Arch Cardiovasc Diseases"},{"key":"B240","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14728214.2017.1269743","article-title":"Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis","volume":"22","author":"Bertrand","year":"2017","journal-title":"Expert Opin Emerging Drugs"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv759","article-title":"Inflammatory cytokines in atherosclerosis: current therapeutic approaches","volume":"37","author":"Tousoulis","year":"2016","journal-title":"Eur Heart J"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2016.06.004","article-title":"Artesunate attenuated progression of atherosclerosis lesion formation alone or combined with rosuvastatin through inhibition of pro-inflammatory cytokines and pro-inflammatory chemokines","volume":"23","author":"Jiang","year":"2016","journal-title":"Phytomedicine Int J Phytotherapy Phytopharmacology"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2017.06.010","article-title":"Ezetimibe and simvastatin combination inhibits and reverses the pro-inflammatory and pro-atherogenic effects of cream in obese patients","volume":"263","author":"Ghanim","year":"2017","journal-title":"Atherosclerosis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1437821\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:34:10Z","timestamp":1727397250000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1437821\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":243,"alternative-id":["10.3389\/fimmu.2024.1437821"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1437821","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,27]]},"article-number":"1437821"}}